ClearPoint Neuro (CLPT) Enterprise Value Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.90% |
| Dec 31, 2025 | -6.97% |
| Sep 30, 2025 | 1.90% |
| Jun 30, 2025 | 2.73% |
| Mar 31, 2025 | 37.05% |
| Dec 31, 2024 | 28.11% |
| Sep 30, 2024 | 27.94% |
| Jun 30, 2024 | 18.88% |
| Mar 31, 2024 | 18.28% |
| Dec 31, 2023 | -4.81% |
| Sep 30, 2023 | -18.33% |
| Jun 30, 2023 | -18.24% |
| Mar 31, 2023 | -23.20% |
| Dec 31, 2022 | -87.45% |
| Sep 30, 2022 | -86.52% |
| Jun 30, 2022 | -82.16% |
| Mar 31, 2022 | -171.12% |
| Dec 31, 2021 | -159.36% |
| Sep 30, 2021 | -149.52% |
| Jun 30, 2021 | -109.43% |
| Mar 31, 2021 | -105.13% |
| Dec 31, 2020 | -29.34% |
| Dec 31, 2019 | -19.76% |
| Sep 30, 2019 | -12.05% |
| Jun 30, 2019 | -54.69% |
| Mar 31, 2019 | 11.40% |
| Dec 31, 2018 | 16.92% |
| Sep 30, 2018 | -26.07% |
| Jun 30, 2018 | -23.92% |
| Mar 31, 2018 | -5.28% |
| Dec 31, 2017 | -0.16% |
| Dec 31, 2016 | 1.94% |
| Sep 30, 2016 | 4.14% |
| Jun 30, 2016 | 33.89% |
| Mar 31, 2016 | 26.97% |
| Dec 31, 2015 | -49.46% |
| Sep 30, 2015 | 21.22% |
| Jun 30, 2015 | -42.24% |
| Mar 31, 2015 | -56.43% |
| Dec 31, 2014 | -299.04% |
| Sep 30, 2014 | -200.11% |
| Jun 30, 2014 | -89.68% |
| Mar 31, 2014 | -768.28% |